Bereich
Infektiologie | Infektionsprävention | Reisemedizin
INFEKT · Dept. I
Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS)
Nüesch R, Bucher H, Battegay M, Calmy A, Thurnheer M, Vernazza P, Cavassini M, Weber R, Bernasconi E, Elzi L, Wang Q, Swiss HIV Cohort Study. Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS). J Acquir Immune Defic Syndr 2013; 62:396-404.
01.04.2013Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS)
01.04.2013J Acquir Immune Defic Syndr 2013; 62:396-404
Nüesch Reto, Bucher Heiner C, Battegay Manuel, Calmy Alexandra, Thurnheer Maria C, Vernazza Pietro, Cavassini Matthias, Weber Rainer, Bernasconi Enos, Elzi Luigia, Wang Qing, Swiss HIV Cohort Study
Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia
Schuetz P, Litke A, Albrich W, Mueller B. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia. Curr Opin Infect Dis 2013; 26:159-67.
01.04.2013Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia
01.04.2013Curr Opin Infect Dis 2013; 26:159-67
Schuetz Philipp, Litke Alexander, Albrich Werner, Mueller Beat
Prosthetic valve endocarditis and bloodstream infection due to Mycobacterium chimaera
Achermann Y, Rössle M, Hoffmann M, Deggim V, Kuster S, Zimmermann D, Bloemberg G, Hombach M, Hasse B. Prosthetic valve endocarditis and bloodstream infection due to Mycobacterium chimaera. J Clin Microbiol 2013; 51:1769-73.
27.03.2013Prosthetic valve endocarditis and bloodstream infection due to Mycobacterium chimaera
27.03.2013J Clin Microbiol 2013; 51:1769-73
Achermann Yvonne, Rössle Matthias, Hoffmann Matthias, Deggim Vanessa, Kuster Stefan, Zimmermann Dieter R, Bloemberg Guido, Hombach Michael, Hasse Barbara
Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial
Drozdov D, Buchkremer F, Litke A, Schuetz P, Huber A, Bürgi U, Fux C, Bock A, Müller B, Albrich W, Ottiger C, Reutlinger B, Thomer A, Meili M, Schwarz S, Kouegbe R, Regez K, Guglielmetti M, Schild U, Conca A, Schäfer P, Triple P study group. Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial. Trials 2013; 14:84.
22.03.2013Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial
22.03.2013Trials 2013; 14:84
Drozdov Daniel, Buchkremer Florian, Litke Alexander, Schuetz Philipp, Huber Andreas, Bürgi Ulrich, Fux Christoph A, Bock Andreas, Müller Beat, Albrich Werner, Ottiger Cornelia, Reutlinger Barbara, Thomer Anja, Meili Marc, Schwarz Stefanie, Kouegbe Rita Bossart, Regez Katharina, Guglielmetti Merih, Schild Ursula, Conca Antoinette, Schäfer Petra, Triple P study group
HIV Infection Disrupts the Sympatric Host-Pathogen Relationship in Human Tuberculosis
Fenner L, Cavassini M, Calmy A, Dolina M, Frei R, Janssens J, Borrell S, Stucki D, Schrenzel J, Böttger E, Gagneux S, Bernasconi E, Hoffmann M, Egger M, Bodmer T, Furrer H, Ballif M, Battegay M, Helbling P, Fehr J, Gsponer T, Rieder H, Zwahlen M, Swiss HIV Cohort and Molecular Epidemiology of Tuberculosis Study Groups. HIV Infection Disrupts the Sympatric Host-Pathogen Relationship in Human Tuberculosis. PLoS Genet 2013; 9:e1003318.
07.03.2013HIV Infection Disrupts the Sympatric Host-Pathogen Relationship in Human Tuberculosis
07.03.2013PLoS Genet 2013; 9:e1003318
Fenner Lukas, Cavassini Matthias, Calmy Alexandra, Dolina Marisa, Frei Reno, Janssens Jean-Paul, Borrell Sonia, Stucki David, Schrenzel Jacques, Böttger Erik C, Gagneux Sebastien, Bernasconi Enos, Hoffmann Matthias, Egger Matthias, Bodmer Thomas, Furrer Hansjakob, Ballif Marie, Battegay Manuel, Helbling Peter, Fehr Jan, Gsponer Thomas, Rieder Hans L, Zwahlen Marcel, Swiss HIV Cohort and Molecular Epidemiology of Tuberculosis Study Groups
The potential impact of biomarker-guided triage decisions for patients with urinary tract infections
Litke A, Mueller B, Reutlinger B, Schäfer P, Conca A, Guglielmetti M, Schild U, Regez K, Bossart R, Albrich W. The potential impact of biomarker-guided triage decisions for patients with urinary tract infections. Infection 2013; 41:799-809.
24.02.2013The potential impact of biomarker-guided triage decisions for patients with urinary tract infections
24.02.2013Infection 2013; 41:799-809
Litke A, Mueller B, Reutlinger B, Schäfer P, Conca A, Guglielmetti M, Schild U, Regez K, Bossart R, Albrich Werner
Efficacy and safety of lersivirine (UK-453,061) versus efavirenz in antiretroviral treatment-naive HIV-1-infected patients: week 48 primary analysis results from an ongoing, multicenter, randomized, double-blind, phase IIb trial
Vernazza P, Craig C, Mori J, Goodrich J, Valdez H, Lazzarin A, Kaplan R, Cooper D, Pulik P, Weil E, Pozniak A, Wang C, Tawadrous M. Efficacy and safety of lersivirine (UK-453,061) versus efavirenz in antiretroviral treatment-naive HIV-1-infected patients: week 48 primary analysis results from an ongoing, multicenter, randomized, double-blind, phase IIb trial. J Acquir Immune Defic Syndr 2013; 62:171-9.
01.02.2013Efficacy and safety of lersivirine (UK-453,061) versus efavirenz in antiretroviral treatment-naive HIV-1-infected patients: week 48 primary analysis results from an ongoing, multicenter, randomized, double-blind, phase IIb trial
01.02.2013J Acquir Immune Defic Syndr 2013; 62:171-9
Vernazza Pietro, Craig Charles, Mori Julie, Goodrich James, Valdez Hernan, Lazzarin Adriano, Kaplan Richard, Cooper David A, Pulik Piotr, Weil Elizabeth, Pozniak Anton, Wang Cunshan, Tawadrous Margaret
Impact of recommendation updates in well-controlled patients on nonrecommended antiretroviral therapies: the Swiss HIV cohort study
Boillat-Blanco N, Wandeler G, Fehr J, Daou S, Elzi L, Adami M, Strahm C, Osih R, Taffé P, Darling K, Cavassini M. Impact of recommendation updates in well-controlled patients on nonrecommended antiretroviral therapies: the Swiss HIV cohort study. J Acquir Immune Defic Syndr 2013; 62:180-9.
01.02.2013Impact of recommendation updates in well-controlled patients on nonrecommended antiretroviral therapies: the Swiss HIV cohort study
01.02.2013J Acquir Immune Defic Syndr 2013; 62:180-9
Boillat-Blanco Noémie, Wandeler Gilles, Fehr Jan, Daou Samira, Elzi Luigia, Adami Maddalena, Strahm Carol, Osih Regina, Taffé Patrick, Darling Katharine E A, Cavassini Matthias
Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial
Albrich W, Conca A, Schäfer P, Schubert M, De Geest S, Reutlinger B, Irani S, Bürgi U, Huber A, Guglielmetti M, Schild U, Rüegger K, Dusemund F, Schuetz P, Arici B, Litke A, Blum C, Bossart R, Regez K, Müller B. Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial. Eur Respir J. 2013; 42:1064-75.
24.01.2013Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial
24.01.2013Eur Respir J. 2013; 42:1064-75
Albrich Werner, Conca Antoinette, Schäfer Petra, Schubert Maria, De Geest Sabina, Reutlinger Barbara, Irani Sarosh, Bürgi Ulrich, Huber Andreas, Guglielmetti Merih, Schild Ursula, Rüegger Kristina, Dusemund Frank, Schuetz Philipp, Arici Birsen, Litke Alexander, Blum Claudine A, Bossart Rita, Regez Katharina, Müller Beat
Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy
Du Pasquier R, Vernazza P, Cavassini M, Günthard H, Cusini A, Gutmann C, Fux C, Yerly S, Kalubi M, Jilek S, Swiss HIV Cohort Study. Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy. AIDS 2013; 27:203-10.
14.01.2013Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy
14.01.2013AIDS 2013; 27:203-10
Du Pasquier Renaud A, Vernazza Pietro, Cavassini Matthias, Günthard Huldrych F, Cusini Alexia, Gutmann Christine, Fux Christoph A, Yerly Sabine, Kalubi Malela, Jilek Samantha, Swiss HIV Cohort Study
Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid
Cusini A, Günthard H, Opravil M, Gutmann C, Zenger F, Klimkait T, Cavassini M, Gaudenz R, Hirschel B, Widmer N, Rohrbach J, Fux C, Ledergerber B, Decosterd L, Yerly S, Vernazza P, Swiss HIV Cohort Study. Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid. J Acquir Immune Defic Syndr 2013; 62:28-35.
01.01.2013Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid
01.01.2013J Acquir Immune Defic Syndr 2013; 62:28-35
Cusini Alexia, Günthard Huldyrich F, Opravil Milos, Gutmann Christine, Zenger Franziska, Klimkait Thomas, Cavassini Matthias, Gaudenz Roman, Hirschel Bernhard, Widmer Nicolas, Rohrbach Janine, Fux Christoph A, Ledergerber Bruno, Decosterd Laurent A, Yerly Sabine, Vernazza Pietro, Swiss HIV Cohort Study
[In Process Citation]
Conca A, Müller B, Schirlo S, Bürgi U, Tobias P, Schweingruber R, Schäfer P, Reutlinger B, Schild U, Regez K, Albrich W. [In Process Citation]. Krankenpfl Soins Infirm 2013; 106:20-3.
01.01.2013[In Process Citation]
01.01.2013Krankenpfl Soins Infirm 2013; 106:20-3
Conca Antoinette, Müller Beat, Schirlo Susanne, Bürgi Ulrich, Tobias Petra, Schweingruber Ruth, Schäfer Petra, Reutlinger Barbara, Schild Ursula, Regez Katharina, Albrich Werner
HIV-infected women in Europe: gender-specific needs and challenges
Bertisch B, Grinsztejn B, Calmy A. HIV-infected women in Europe: gender-specific needs and challenges. Antivir Ther (Lond) 2013; 18:549-51.
01.01.2013HIV-infected women in Europe: gender-specific needs and challenges
01.01.2013Antivir Ther (Lond) 2013; 18:549-51
Bertisch Barbara, Grinsztejn Beatriz, Calmy Alexandra
Relevance of cohort studies for the study of transplant infectious diseases
Christoph B, Mueller N, Maja W, Nadal D, Meylan P, Manuel O, Koller M, Khanna N, Hirsch H, Garzoni C, Van Delden C, Cusini A, Boggian K, Transplant Infectious Diseases Working Group, Swiss Transplant Cohort Study. Relevance of cohort studies for the study of transplant infectious diseases. Curr Opin Organ Transplant 2012; 17:581-585.
01.12.2012Relevance of cohort studies for the study of transplant infectious diseases
01.12.2012Curr Opin Organ Transplant 2012; 17:581-585
Christoph Berger, Mueller Nicolas J, Maja Weisser, Nadal David, Meylan Pascal, Manuel Oriol, Koller Michael, Khanna Nina, Hirsch Hans H, Garzoni Christian, Van Delden Christian, Cusini Alexia, Boggian Katia, Transplant Infectious Diseases Working Group, Swiss Transplant Cohort Study
Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens
Scherrer A, Günthard H, Ledergerber B, Bernasconi E, Vernazza P, Elzi L, Cavassini M, Calmy A, Furrer H, Aubert V, Klimkait T, Yerly S, Böni J, Swiss HIV Cohort Study (SHCS). Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens. PloS one 2012; 7:e50307.
26.11.2012Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens
26.11.2012PloS one 2012; 7:e50307
Scherrer Alexandra U, Günthard Huldrych F, Ledergerber Bruno, Bernasconi Enos, Vernazza Pietro, Elzi Luigia, Cavassini Matthias, Calmy Alexandra, Furrer Hansjakob, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Böni Jürg, Swiss HIV Cohort Study (SHCS)
Efficacy and Safety of Lersivirine (UK-453,061) versus Efavirenz in Antiretroviral Treatment-Naïve HIV-1-Infected Patients: Week 48 Primary Analysis Results from an Ongoing, Multicenter, Randomized, Double-Blind, Phase IIb Trial
Vernazza P, Craig C, Mori J, Goodrich J, Valdez H, Lazzarin A, Kaplan R, Cooper D, Pulik P, Weil E, Pozniak A, Wang C, Tawadrous M. Efficacy and Safety of Lersivirine (UK-453,061) versus Efavirenz in Antiretroviral Treatment-Naïve HIV-1-Infected Patients: Week 48 Primary Analysis Results from an Ongoing, Multicenter, Randomized, Double-Blind, Phase IIb Trial. J Acquir Immune Defic Syndr 2012
31.10.2012Efficacy and Safety of Lersivirine (UK-453,061) versus Efavirenz in Antiretroviral Treatment-Naïve HIV-1-Infected Patients: Week 48 Primary Analysis Results from an Ongoing, Multicenter, Randomized, Double-Blind, Phase IIb Trial
31.10.2012J Acquir Immune Defic Syndr 2012
Vernazza Pietro, Craig Charles, Mori Julie, Goodrich James, Valdez Hernan, Lazzarin Adriano, Kaplan Richard, Cooper David A, Pulik Piotr, Weil Elizabeth, Pozniak Anton, Wang Cunshan, Tawadrous Margaret
A traveller presenting with severe melioidosis complicated by a pericardial effusion: a case report
Schultze D, Müller B, Bruderer T, Dollenmaier G, Riehm J, Boggian K. A traveller presenting with severe melioidosis complicated by a pericardial effusion: a case report. BMC Infect Dis 2012; 12:242.
04.10.2012A traveller presenting with severe melioidosis complicated by a pericardial effusion: a case report
04.10.2012BMC Infect Dis 2012; 12:242
Schultze Detlev, Müller Brigitt, Bruderer Thomas, Dollenmaier Günter, Riehm Julia M, Boggian Katia
[HIV test and prevention]
Bickel A, Vernazza P. [HIV test and prevention]. Internist (Berl) 2012; 53:1179-86.
01.10.2012[HIV test and prevention]
01.10.2012Internist (Berl) 2012; 53:1179-86
Bickel A, Vernazza Pietro
An uncommon reason for dyspnoea: phrenic paresis secondary to alveolar echinococcosis
Wassmer P, Chronis J, Rüdiger J, Boggian K. An uncommon reason for dyspnoea: phrenic paresis secondary to alveolar echinococcosis. Eur Respir J. 2012; 40:1053-5.
01.10.2012An uncommon reason for dyspnoea: phrenic paresis secondary to alveolar echinococcosis
01.10.2012Eur Respir J. 2012; 40:1053-5
Wassmer Philipp, Chronis Joannis, Rüdiger Jochen, Boggian Katia
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study
Weber R, the Swiss HIV Cohort Study (SHCS), Schultze D, Schöni-Affolter F, Schüpbach J, Speck R, Taffé P, Tarr P, Telenti A, Trkola A, Vernazza P, Ledergerber B, Kowalska J, Ruppik M, Rickenbach M, Spoerri A, Furrer H, Battegay M, Cavassini M, Calmy A, Bernasconi E, Schmid P, Flepp M, Yerly S. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med 2012
24.09.2012Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study
24.09.2012HIV Med 2012
Weber R, the Swiss HIV Cohort Study (SHCS), Schultze D, Schöni-Affolter F, Schüpbach J, Speck R, Taffé P, Tarr P, Telenti A, Trkola A, Vernazza Pietro, Ledergerber B, Kowalska J, Ruppik M, Rickenbach M, Spoerri A, Furrer H, Battegay M, Cavassini M, Calmy A, Bernasconi E, Schmid P, Flepp M, Yerly S